Going Blind film at World Ophthalmology Congress

Article

Joe Lovett's film, Going Blind will be screened at the World Ophthalmology Congress in Berlin in June. Ophthalmology Times Europe strongly recommends that all doctors put this on their schedule if they are visiting the congress.

Joe Lovett's film, Going Blind will be screened at the World Ophthalmology Congress in Berlin in June. Ophthalmology Times Europe strongly recommends that all doctors put this on their schedule if they are visiting the congress. The movie will be screened at 18:00-20:00 in the Stockholm Room.

US documentary film director, Joe, was diagnosed with glaucoma 22 years ago and since then he has been progressively losing his vision. Six years ago, he decided to make his film to document the impact that blindness had on people’s lives and also to relay his own experience with the condition.

Joe wants to make the public more aware of the importance of regular eye exams and low vision aids. He also wants to highlight the importance of patient quality of life and education to the ophthalmology community, as well as to provide specialists with a tool for their own patient education initiatives.

Joe told OTEurope: “We have been getting an extraordinary response to the film among ophthalmologists. August Colenbrander, MD, one of the leading low vision experts in the world, was particularly taken with the film and has encouraged the WOC to have a special screening of the film on June 8th in Berlin.”

Joe's plea is: “There are too many people with vision loss who could benefit from much earlier diagnosis and intervention and dramatically increased awareness of what's possible in vision rehabilitation. I would ask that physicians don't wait until we've lost much of our vision before they talk to us about vision rehabilitation, including the services and resources that can help us live most effectively and plan positively for the future.

“Please refer us to these specialists and don't ever tell patients that there is nothing more that can be done! There are always new skills to learn. Enormous progress has come through the power of strong advocates. We have many disability role models who broke the rules and made stunning progress! We need to do the same to increase public awareness of sight loss!

““This is our challenge. Our hope is that our film, Going Blind will play some small part. ”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.